Cytarabine and Irritable bowel syndrome - a phase IV clinical study of FDA data
Irritable bowel syndrome is reported only by a few people who take Cytarabine.
The phase IV clinical study analyzes which people take Cytarabine and have Irritable bowel syndrome. It is created by eHealthMe based on reports of 47,201 people who have side effects while taking Cytarabine from the FDA, and is updated regularly.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
47,201 people reported to have side effects when taking Cytarabine.
Among them, 5 people (0.01%) have Irritable bowel syndrome.
What is Cytarabine?
Cytarabine has active ingredients of cytarabine. It is often used in acute myelogenous leukemia (aml) - adult. eHealthMe is studying from 47,240 Cytarabine users for its effectiveness, alternative drugs and more.
What is Irritable bowel syndrome?
Irritable bowel syndrome is found to be associated with 2,508 drugs and 1,950 conditions by eHealthMe.
Number of Cytarabine and Irritable bowel syndrome reports submitted per year:
Time on Cytarabine when people have Irritable bowel syndrome *:
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Irritable bowel syndrome when taking Cytarabine *:
- female: 0.0 %
- male: 100 %
Age of people who have Irritable bowel syndrome when taking Cytarabine *:
- 0-1: 0.0 %
- 2-9: 25 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 25 %
- 60+: 50 %
Common drugs people take besides Cytarabine *:
- Etoposide: 3 people, 60.00%
- Isotretinoin: 2 people, 40.00%
- Venclexta: 2 people, 40.00%
- Rituxan: 2 people, 40.00%
- Revlimid: 2 people, 40.00%
- Cyclophosphamide: 2 people, 40.00%
- Ibrutinib: 1 person, 20.00%
- Allopurinol: 1 person, 20.00%
- Atracurium Besylate: 1 person, 20.00%
- Bendamustine: 1 person, 20.00%
Common side effects people have besides Irritable bowel syndrome *:
- Diarrhea: 4 people, 80.00%
- Insomnia (sleeplessness): 3 people, 60.00%
- Inflammatory Bowel Disease: 3 people, 60.00%
- Intestinal Obstruction: 2 people, 40.00%
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 40.00%
- Anaemia (lack of blood): 2 people, 40.00%
- Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 40.00%
- Blindness: 2 people, 40.00%
- Colitis (inflammation of colon): 2 people, 40.00%
- Confusional State: 2 people, 40.00%
Common conditions people have *:
- Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 3 people, 60.00%
- Acne (skin problems that cause pimples): 3 people, 60.00%
- Lymphocytic Leukaemia (a type of cancer in which the bone marrow makes too many lymphocytes): 1 person, 20.00%
- Infection: 1 person, 20.00%
- Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 20.00%
* Approximation only. Some reports may have incomplete information.
Do you take Cytarabine and have Irritable bowel syndrome?Check whether Irritable bowel syndrome is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of Cytarabine:
- Cytarabine (47,240 reports)
Irritable bowel syndrome treatments and more:
- Irritable bowel syndrome (39,320 reports)
COVID vaccines that are related to Irritable bowel syndrome:
- Irritable bowel syndrome in Moderna COVID Vaccine
- Irritable bowel syndrome in Pfizer BioNTech Covid Vaccine
- Irritable bowel syndrome in Johnson and Johnson Covid Vaccine
How severe was Irritable bowel syndrome and when was it recovered:
Expand to all the drugs that have ingredients of cytarabine:
Common drugs associated with Irritable bowel syndrome:
All the drugs that are associated with Irritable bowel syndrome:
- Irritable bowel syndrome (2,508 drugs)
Common conditions associated with Irritable bowel syndrome:
All the conditions that are associated with Irritable bowel syndrome:
- Irritable bowel syndrome (1,950 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on cytarabine (the active ingredients of Cytarabine) and Cytarabine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.